Asia Pacific Animal Parasiticides Market by Type [Ectoparasiticides (Pour-ons & Spot-ons, Dips), Endoparasiticides (Oral Liquids, Injectables, Feed Additives), Endectocides], Animal Type (Companion Animals, Livestock), End User - Forecast to 2031

icon1
USD 3.20 BN
MARKET SIZE, 2031
icon2
CAGR 7.2%
(2026-2031)
icon3
300
REPORT PAGES
icon4
280
MARKET TABLES

OVERVIEW

asia-pacific-animal-parasiticides-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The Asia Pacific animal parasiticides market, valued at US$2.12 billion in 2025, stood at US$2.26 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of US$3.20 billion by the end of the period. The Asia Pacific animal parasiticides market is growing due to rising levels of parasite infestation among livestock and companion animals, expanding animal populations, and greater focus on preventive animal healthcare. The demand for parasiticides that offer long-acting doses, combinations, and ease of administration is increasingly supported by higher investments in animal care and enhanced veterinary infrastructure throughout the region. The regional spread is also fueled by the adoption of modern farm management practices and stronger disease control initiatives.

KEY TAKEAWAYS

  • By Country
    China is expected to register the highest CAGR of 8.9% from 2026 to 2031.
  • By Type
    By type, the ectoparasiticides segment is expected to register the highest CAGR of 8.1% during the forecast period.
  • By Animal Type
    By animal type, the companion animals segment dominated the market by accounting for 57.8% share in 2025.
  • By End User
    By end user, the veterinary hospitals & clinics segment led the market, with a share of 59.8% in 2025.
  • Competitive Landscape - Key Players
    Zoetis Services LLC (US), Merck & Co., Inc. (US), and Boehringer Ingelheim International GmbH (Germany) were identified as some of the star players in the Asia Pacific animal parasiticides market, given their extensive global reach and comprehensive product portfolios.
  • Competitive Landscape - Startups
    Abbey Labs (Australia), Alivira Animal Health Limited (India), and Headway Animal Health (Australia) have distinguished themselves among startups and SMEs by due to their strong product portfolio and business strategy.

The growing prevalence of parasites in livestock and companion animals has led to a rise in the Asia Pacific animal parasiticides markets due to warm climatic conditions and intensifying farming practices. Increased companion animal ownership and substantial spending on preventive veterinary care, coupled with awareness of dangers posed by zoonotic diseases, have also spurred demand for animal parasiticides. Other factors driving market growth include improved regional veterinary infrastructure, stringent disease-control regulations, and the rising adoption of long-acting and combination parasiticides.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Trends shaping this market include increasing demand for preventive parasite control, growing ownership of companion animals, expanding livestock production, and greater awareness of the risks posed by zoonotic diseases. Primary adopters of innovative parasiticide solutions, such as animal health companies, are increasingly seeking contract manufacturers and CDMOs based in Asia Pacific for the development of sustainable formulations, optimization of delivery systems, and scalable manufacturing. The need for easy-to-administer, long-acting, and compliance-friendly treatments, together with the integration of digital farm management and parasite surveillance, is driving product development and commercialization strategies across Asia Pacific. The growing reliance on integrated formulations, regional outsourcing partnerships, and innovation-driven differentiation in the Asia Pacific animal parasiticides ecosystem is a key factor shaping market growth.

asia-pacific-animal-parasiticides-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • High parasite prevalence due to warm, humid climates
  • Growing population of companion animals and livestock
RESTRAINTS
Impact
Level
  • Strict regulations on parasiticide residues in food-producing animals
  • Growing parasite resistance
OPPORTUNITIES
Impact
Level
  • Development of long-acting and controlled-release parasiticides
  • Growth of veterinary CDMOs and local manufacturing in Asia Pacific
CHALLENGES
Impact
Level
  • Managing and delaying parasiticide resistance
  • Navigating diverse regulatory framework

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: High parasite prevalence due to warm, humid climates

At present, the high prevalence of parasites is a key driver of the Asia Pacific animal parasiticides market, largely due to the region’s warm, humid climate and tropical weather patterns associated with its geographic location. These conditions provide an optimal environment for ticks, fleas, mites, lice, and a wide range of internal parasites to survive and proliferate. As a result, there is a sustained and ongoing demand for parasiticides for both preventive and curative management of parasite-related diseases across the Asia Pacific region.

Restraint: Strict regulations on parasiticide residues in food-producing animals

Strict regulations on parasiticide residues in food-producing animals represent a significant restraint, particularly for export-oriented countries in the Asia Pacific region where food safety standards are highly stringent. Compliance requirements related to maximum residue limits, withdrawal periods, environmental impact, and animal welfare increase regulatory complexity and substantially raise the cost of new product development. These challenges can delay product launches, limit the use of certain active ingredients, and reduce operational flexibility for both manufacturers and livestock producers.

Opportunity: Development of long-acting and controlled-release parasiticides

The development of long-acting and controlled release parasiticides is a great opportunity because of challenges associated with frequent administration, high labor intensity, and lack of compliance when taking the drugs. The advantage of these drugs is that they provide prolonged protection with fewer administrations, which will benefit farming enterprises where large numbers of animals are handled, as well as pet owners. Through these offerings, differentiation of portfolios can now occur for players in the industry.

Challenge: Managing and delaying parasiticide resistance

Resistance management and the delaying of parasiticide resistance are among the important challenges in the animal parasiticides market in the Asia Pacific region. This is mainly because of repeated use of the same active ingredient and class, misuse of dosing, and inadequate rotation of classes used for treatments. As there is an increased level of resistance, there is diminished efficacy and effectiveness of the products, as well as rising economic costs for farmers and consumers.

ASIA PACIFIC ANIMAL PARASITICIDES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers an extensive parasiticides portfolio for companion animals (e.g., Simparica, Revolution/Stronghold) and livestock, alongside vaccines, diagnostics, and animal health solutions sold across Asia Pacific Provides broad parasite control across species | supports preventive health and herd/clinic productivity with widely recognized brands
Develops and commercializes parasiticide products such as BRAVECTO (including long-acting formulations) for fleas, ticks, and internal parasites in dogs/cats and livestock globally including Asia Pacific Enhances treatment adherence with long-acting protection |reduces parasite burden | strengthen field performance for vets and owners
Provides animal health products, including parasiticides, for companion and production animals, leveraging global R&D and product distribution networks Delivers preventive and therapeutic parasite solutions across species | supports veterinary practice needs in Asia Pacific markets
Supplies parasiticides as part of its broader veterinary pharmaceutical portfolio for pets and livestock, targeting fleas, ticks, mites, internal worms, and related conditions Improves animal health outcomes | supports farm efficiency | supplies vets and farmers with effective parasite control options
Offers a wide range of parasiticides (external and internal) for companion animals and livestock, supported by localized subsidiaries and R&D in multiple regions Provides region-adapted parasite solutions |strengthens animal health services |supports parasite prevention and treatment

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The Asia Pacific ecosystem of animal parasiticides comprises a multitude of players, ranging from product manufacturers (multinational companies and regional formulators producing ectoparasiticides, endoparasiticides, and endectocides); ingredient suppliers; contract R&D/CDMO partners who develop and scale formulations; distributors and wholesalers (traditional pharma distributors, veterinary wholesalers, and e-commerce channels with fast-growing sales); end users such as commercial livestock producers, companion-animal clinics, smallholder farmers, and pet owners; service providers such as veterinary clinics, diagnostic and reference laboratories, and field extension services; agencies for regulators and government procurement that set the standards for approval, residues, and use; and supporting stakeholders like vets’ associations, feed companies, contract research organizations, and academic laboratories, who together shape product acceptance, surveillance, stewardship, and market access across the varied regulatory and production landscape within the region.

asia-pacific-animal-parasiticides-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

asia-pacific-animal-parasiticides-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Asia Pacific Animal Parasiticides Market, by Type

In 2025, ectoparasiticides accounted for the largest share of the Asia Pacific animal parasiticides market, primarily due to the widespread presence of ticks, fleas, and mites across tropical and subtropical climate zones. Increasing awareness of vector-borne diseases and their significant economic impact on livestock and companion animals has driven the regular use of preventive treatments. Demand has been further supported by the ease of topical administration, broad product availability, and high adoption among companion animals, resulting in higher and more frequent usage than other parasiticide classes.

Asia Pacific Animal Parasiticides Market, by Animal Type

In 2025, companion animals dominated the Asia Pacific animal parasiticides market, which is driven by a growing number of pet owners, rapid urbanization, and a rising trend of considering pets as family members among key countries. Pet owners demonstrated greater readiness to pay for preventive measures to control parasites, particularly ectoparasites. The prominent presence of veterinary practices, retail, and e-commerce helped facilitate regular use among companion animals.

Asia Pacific Animal Parasiticides Market, by End User

In 2025, veterinary hospitals and clinics accounted for the largest share of the Asia Pacific animal parasiticides market as they represent the main source of diagnosis, prescription, and provision of preventive measures. Prescription medications and prescribed products command a larger amount of trust, compliance, and sales of branded products. In fact, the rising number of city-based clinics and the clinic attendance of pet owners contributed to higher sales of products from this source.

REGION

China to be fastest-growing country in Asia Pacific animal parasiticides market during forecast period

China is likely to be the fastest-growing market for animal parasiticides in the Asia Pacific region, driven by rising companion animal ownership and increasing urban incomes that support higher spending on pet healthcare. At the same time, the scaling and modernization of livestock farming are boosting demand for effective parasite control to reduce productivity losses and disease transmission. Growth is further supported by greater awareness of zoonotic and vector-borne diseases, the expanding network of veterinary clinics and hospitals, and improved access to parasiticides through e-commerce and organized retail channels nationwide.

asia-pacific-animal-parasiticides-market Region

ASIA PACIFIC ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX

In the Asia Pacific animal parasiticides market, Zoetis (Star) is ranked at the top position, which is supported by its wide product portfolio of ectoparasiticides, endoparasiticides, and endectocides for both companion and food-producing animals. The company's dominance is sustained by its strong R&D capabilities, continuous product innovation, and a vast distribution and veterinary network in the leading Asia Pacific markets. Virbac (Emerging Leader) is becoming popular very quickly, especially in the field of parasiticides for companion animals, which is a result of its concentrate veterinary-only strategy, differentiation formulations, and Asiatic footprint extension. As the top animal health companies keep on investing in preventive care, portfolio expansion, and regional manufacturing, the rise of Zoetis and Virbac in Asia Pacific is going to the core of the dynamics of the evolution of animal parasiticides in the region.

asia-pacific-animal-parasiticides-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 2.12 BN
Market Forecast in 2031 (Value) USD 3.20 BN
Growth Rate CAGR of 7.2% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Billion), Volume (Thousand Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Type:
    • Ectoparasiticides
    • Endoparasiticides
    • Endectocides
  • By Animal Type:
    • Companion Animals
    • Livestock
  • By End User:
    • Veterinary Hospitals & Clinics
    • Animal Farms
    • Home Care Settings
Countries Covered China, Japan, India, Australia, South Korea, Thailand, Vietnam, New Zealand, Indonesia, Philippines, Rest of Asia Pacific

WHAT IS IN IT FOR YOU: ASIA PACIFIC ANIMAL PARASITICIDES MARKET REPORT CONTENT GUIDE

asia-pacific-animal-parasiticides-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Compared different key parasiticide types for animals marketed in Asia Pacific, such as ectoparasiticides, endoparasiticides, and endectocides Evaluated whether used for prevention or treatment, by animal type (pets versus livestock), and product differentiation among major companies in Asia Pacific Facilitated clarity into product maturity, usage dynamics, and demand gaps, thereby aiding in portfolio optimization, pricing decisions, and prioritized focus on high-growth parasiticide markets
Company Information Profiled major animal health firms operating in the Asia Pacific region such as Zoetis, MSD Animal Health, Boehringer Ingelheim, Elanco, Virbac, and major local players Assessed their product portfolios, R&D investments, manufacturing, and distribution networks in major Asia Pacific countries
Geographic Analysis Carried out in-depth regional analysis in China, India, Japan, Australia, and Rest of Asia Pacific regarding the prevalence of parasitic diseases, farm animal density, and companion animal market trends Assisted in the development of regional strategies for finding the fastest-growing countries, the level of complexity for regulations, opportunities for localizations, and markets to pursue in the Asia Pacific region

RECENT DEVELOPMENTS

  • July 2025 : Merck & Co., Inc. announced that the US FDA approved BRAVECTO QUANTUM, an extended-release injectable suspension administered annually to treat and protect dogs against fleas and ticks.
  • April 2025 : Zoetis Services LLC announced that the US FDA approved the expansion of the indication for Simparica Trio. It is a combination parasiticide for canines that prevents flea tapeworm infections.
  • April 2024 : Zoetis Services LLC and Phibro Animal Health Corporation unveiled a definitive agreement whereby Phibro purchased Zoetis' medicated feed additive portfolio that also includes a few water-soluble products and related assets for USD 350 ?‍?‌‍?‍‌?‍?‌‍?‍‌million.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMICS INDICATORS
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.3
TRENDS IN ASIA PACIFIC HEALTHCARE INDUSTRY
 
 
 
 
5.2.4
TRENDS IN ASIA PACIFIC ANIMAL HEALTH INDUSTRY
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND, BY COUNTRY (2023-2025)
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE (2023-2025)
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 3004)
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 3004)
 
 
 
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
5.12
IMPACT OF 2025 US TARIFF – APAC ANIMAL PARASITICIDES MARKET
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.12.4
IMPACT ON COUNTRIES
 
 
 
 
 
5.12.4.1
CHINA
 
 
 
 
5.12.4.2
JAPAN
 
 
 
 
5.12.4.3
INDIA
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
5.12.5.1
VETERINARY HOSPITALS & CLINICS
 
 
 
 
5.12.5.2
ANIMAL FARMS
 
 
 
 
5.12.5.3
HOME CARE SETTINGS
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
6.1.1
LONG-ACTING / EXTENDED-RELEASE PARASITICIDES
 
 
 
 
6.1.2
NEXT-GEN ANTIPARASITIC VACCINES
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.2.1
PRECISION LIVESTOCK FARMING (PLF) SENSORS & WEARABLES
 
 
 
 
6.2.2
NANOBIOSENSORS & RAPID DIAGNOSTICS FOR PARASITES
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
6.3.1
PRECISION PARASITE MANAGEMENT
 
 
 
 
6.3.2
ENTOMOPATHOGENIC FUNGI (EPF) FOR TICKS & ECTOPARASITES
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON APAC ANIMAL PARASITICIDES MARKET
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.7.2
BEST PRACTICES IN APAC ANIMAL PARASITICIDES MARKET
 
 
 
 
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN THE APAC ANIMAL PARASITICIDES MARKET
 
 
 
 
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN APAC ANIMAL PARASITICIDES MARKET
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
7.2.1
ENERGY-EFFICIENT SYSTEM DESIGN AND USE OF RECYCLABLE MATERIALS IN ANIMAL PARASITICIDE PRODUCTS
 
 
 
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
9
APAC ANIMAL PARASITICIDES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY ANIMAL PARASITICIDES TYPES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
APAC VOLUME ANALYSIS OF ANIMAL PARASITICIDES, 2024 – 2031 (THOUSAND UNITS)
 
 
 
 
9.3
ECTOPARASITICIDES
 
 
 
 
 
9.3.1
POUR-ONS & SPOT-ONS
 
 
 
 
9.3.2
ORAL TABLETS
 
 
 
 
9.3.3
SPRAYS
 
 
 
 
9.3.4
DIPS
 
 
 
 
9.3.5
EAR TAGS
 
 
 
 
9.3.6
COLLARS
 
 
 
 
9.3.7
OTHER ECTOPARASITICIDES
 
 
 
9.4
ENDOPARASITICIDES
 
 
 
 
 
9.4.1
ORAL LIQUIDS
 
 
 
 
9.4.2
ORAL SOLIDS
 
 
 
 
9.4.3
INJECTABLES
 
 
 
 
9.4.4
FEED ADDITIVES
 
 
 
 
9.4.5
OTHER ENDOPARASITICIDES
 
 
 
9.5
ENDECTOCIDES
 
 
 
 
NOTE: OTHER ECTOPARASITICIDES INCLUDE SHAMPOOS, SOAPS, POWDERS, CREAMS, AND DUSTS.
 
 
 
 
 
NOTE: OTHER ENDOPARASITICIDES INCLUDE GELS AND ORAL PASTES.
 
 
 
 
10
APAC ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
ANIMAL WISE DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING ANIMAL PARASITICIDES ADOPTION IN DIVERSE INDUSTRIES
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
COMPANION ANIMALS
 
 
 
 
 
10.2.1
DOGS
 
 
 
 
10.2.2
CATS
 
 
 
 
10.2.3
HORSES
 
 
 
 
10.2.4
OTHER COMPANION ANIMALS
 
 
 
10.3
LIVESTOCK
 
 
 
 
 
10.3.1
CATTLE
 
 
 
 
10.3.2
PIGS
 
 
 
 
10.3.3
POULTRY
 
 
 
 
10.3.4
SHEEPS & GOATS
 
 
 
 
10.3.5
OTHER LIVESTOCK
 
 
 
NOTE: OTHER COMPANION ANIMALS INCLUDE RABBITS, REPTILES, FISH, BIRDS, AND SMALL MAMMALS LIKE MICE, HAMSTERS, GUINEA PIGS, AND HEDGEHOGS.
 
 
 
 
 
NOTE: OTHER LIVESTOCK INCLUDES AQUATIC ANIMALS.
 
 
 
 
11
APAC ANIMAL PARASITICIDES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
VETERINARY HOSPITALS & CLINICS
 
 
 
 
11.3
ANIMAL FARMS
 
 
 
 
11.4
HOME CARE SETTINGS
 
 
 
12
APAC ANIMAL PARASITICIDES MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
 
 
 
 
 
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY COUNTRIES
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
12.2
ASIA PACIFIC
 
 
 
 
12.3
ASIA PACIFIC VOLUME ANALYSIS – 2024 – 2031 (THOUSAND UNITS)
 
 
 
 
12.4
MACROECONOMIC OUTLOOK FOR APAC
 
 
 
 
12.5
CHINA
 
 
 
 
12.6
JAPAN
 
 
 
 
12.7
INDIA
 
 
 
 
12.8
AUSTRALIA
 
 
 
 
12.9
SOUTH KOREA
 
 
 
 
12.10
THAILAND
 
 
 
 
12.11
VIETNAM
 
 
 
 
12.12
NEW ZEALAND
 
 
 
 
12.13
INDONESIA
 
 
 
 
12.14
PHILIPPINES
 
 
 
 
12.15
REST OF ASIA PACIFIC
 
 
 
 
NOTE: REST OF ASIA PACIFIC INCLUDES BANGLADESH, BHUTAN, NEPAL, SRI LANKA, SINGAPORE, TAIWAN AND CAMBODIA.
 
 
 
 
16
COMPETITIVE LANDSCAPE
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
16.1
OVERVIEW
 
 
 
 
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
16.3
ASIA PACIFIC REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021-2025)
 
 
 
 
16.4
ASIA PACIFIC MARKET SHARE ANALYSIS,
 
 
 
 
 
16.5
PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
16.5.1
ZOETIS SERVICES LLC (SIMPARICA)
 
 
 
 
16.5.2
ELANCO (COMFORTIS)
 
 
 
 
16.5.3
BOEHRINGER INGELHEIM INTERNATIONAL GMBH (NEXGARD)
 
 
 
16.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
16.6.1
STARS
 
 
 
 
16.6.2
EMERGING LEADERS
 
 
 
 
16.6.3
PERVASIVE PLAYERS
 
 
 
 
16.6.4
PARTICIPANTS
 
 
 
 
16.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
16.6.5.1
COMPANY FOOTPRINT
 
 
 
 
16.6.5.2
REGION FOOTPRINT
 
 
 
 
16.6.5.3
TYPE FOOTPRINT
 
 
 
 
16.6.5.4
ANIMAL TYPE FOOTPRINT
 
 
16.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
16.7.1
PROGRESSIVE COMPANIES
 
 
 
 
16.7.2
RESPONSIVE COMPANIES
 
 
 
 
16.7.3
DYNAMIC COMPANIES
 
 
 
 
16.7.4
STARTING BLOCKS
 
 
 
 
16.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
16.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
16.7.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
16.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
16.9
COMPETITIVE SCENARIO
 
 
 
 
 
16.9.1
PRODUCT LAUNCHES
 
 
 
 
16.9.2
DEALS
 
 
 
 
16.9.3
EXPANSIONS
 
 
 
 
16.9.4
OTHER DEVELOPMENTS
 
 
17
COMPANY PROFILES
 
 
 
 
 
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE APAC ANIMAL PARASITICIDES MARKET LANDSCAPE
 
 
 
 
 
17.1
KEY PLAYERS
 
 
 
 
 
17.1.1
ZOETIS SERVICES LLC
 
 
 
 
17.1.2
MERCK & CO., INC.
 
 
 
 
17.1.3
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
 
 
 
 
17.1.4
ELANCO
 
 
 
 
17.1.5
VIRBAC
 
 
 
 
17.1.6
CEVA
 
 
 
 
17.1.7
VETOQUINOL
 
 
 
 
17.1.8
NORBROOK
 
 
 
 
17.1.9
PHIBRO ANIMAL HEALTH CORPORATION
 
 
 
 
17.1.10
BIMEDA CORPORATE
 
 
 
 
17.1.11
PETIQ, LLC
 
 
 
17.2
OTHER PLAYERS
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
18.1
RESEARCH DATA
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
18.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
18.1.2.4
KEY INDUSTRY INSIGHTS
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
18.2.1
BOTTOM-UP APPROACH
 
 
 
 
18.2.2
TOP-DOWN APPROACH
 
 
 
 
18.2.3
BASE NUMBER CALCULATION
 
 
 
18.3
MARKET FORECAST APPROACH
 
 
 
 
 
18.3.1
SUPPLY SIDE
 
 
 
 
18.3.2
DEMAND SIDE
 
 
 
18.4
DATA TRIANGULATION
 
 
 
 
18.5
FACTOR ANALYSIS
 
 
 
 
18.6
RESEARCH ASSUMPTIONS
 
 
 
 
18.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
19
APPENDIX
 
 
 
 
 
19.1
DISCUSSION GUIDE
 
 
 
 
19.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
19.3.1
PRODUCT ANALYSIS
 
 
 
 
19.3.2
COMPANY INFORMATION
 
 
 
 
19.3.3
GEOGRAPHIC ANALYSIS
 
 
 
 
19.3.4
COUNTRY LEVEL MARKET SHARE ANALYSIS
 
 
 
 
19.3.5
COUNTRY LEVEL VOLUME ANALYSIS
 
 
 
 
19.3.6
BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
 
 
 
 
19.3.7
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
 
 
 
19.4
RELATED REPORTS
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 
 
*CONTENTS IN THE TOC/ MARKET SEGMENTS ARE TENTATIVE AND MIGHT CHANGE AS THE RESEARCH PROCEEDS.
 
 
 
 
 
*LIST OF COMPANIES IS NOT EXHAUSTIVE AND MIGHT CHANGE DURING COURSE OF STUDY
 
 
 
 

 

Methodology

The market size for Asia Pacific animal parasiticides was estimated using four main methods in this study. The market, as well as its peer and parent markets, were the subject of extensive research. The subsequent phase involved doing primary research to confirm these conclusions, presumptions, and estimates with industry professionals across the value chain. For the purpose of estimating the value market, top-down and bottom-up strategies were both used. The market size of segments and subsegments was then estimated using market breakdown and data triangulation processes.

Secondary Research

There were several secondary sources used in this study, including directories, databases like Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, corporate house documents, investor presentations, and firm SEC filings. In order to find and gather data for the detailed, technical, market-focused, and commercial analysis of the Asia Pacific animal parasiticides market, secondary research was carried out. Relevant information on major companies, market classification and segmentation according to industry trends down to the most basic level, and significant changes regarding market and technological views were also obtained. Additionally, utilizing secondary research, a database of the important industry executives was created.

Primary Research

To gather qualitative and quantitative data for this study, a variety of sources from the supply and demand sides were interviewed during the main research phase. CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of animal parasiticide manufacturing businesses, key opinion leaders, suppliers, and distributors are the main sources on the supply side. Veterinary hospitals and clinics, research facilities, academic institutions, and contract manufacturing companies are some of the main demand-side suppliers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for Asia Pacific animal parasiticides was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for Asia Pacific animal parasiticides was calculated using data from four distinct sources, as will be discussed below:

Data Triangulation

The entire market was split up into a number of segments and subsegments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments and subsegments.

Approach to derive the market size and estimate market growth

Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of Asia Pacific animal parasiticides. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market definition

Animal parasiticides, often known as antiparasitics, are drugs used to stop, reduce and cure internal and external parasite infestations in pets and cattle. Ectoparasiticides, endoparasiticides, and endectocides are the typical subcategories of parasiticides. They come in a variety of deliverable forms, including liquids for oral use, pills, injectables, pour-ons, spot-ons, drenches, ear tags, collars, and sprays. Depending on the kind of parasite, the kind of animal, and the quantity of animals to be treated, a parasiticide is chosen.

Key Stakeholders

  • Animal Parasiticide Manufacturers
  • Animal Parasiticide Distributors
  • Animal Health R&D Companies
  • Veterinary Clinics and Hospitals
  • Veterinary Pharmaceutical Associations
  • Veterinary Research Institutes and Universities
  • Venture Capitalists and Investors
  • Market Research and Consulting Firms
  • Government Associations

Objectives of the Study

  • To define, characterize, segment, and forecast the market for Asia Pacific animal parasiticides based on type, animal type, end user, and region
  • To provide comprehensive information on the key elements affecting the market's growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To evaluate the market for Asia Pacific animal parasiticides in light of the Porter's Five Forces, the regulatory environment, the value chain, the supply chain, the ecosystem, patent protection, and the effects of the recession
  • To evaluate micromarkets with regard to their unique growth trends, prospects, and market contributions
  • To assess market prospects for participants and give information on the competitive environment
  • To list prominent market participants and thoroughly assess all of their essential abilities
  • To monitor and assess market competition through actions including product introductions and approvals, acquisitions, growth, alliances, and agreements

Available Customizations

MarketsandMarkets provides modifications based on the provided market data to suit the unique requirements of the organization. The report can be customized in the ways shown below:

Product Analysis

  • Product matrix, which compares the product portfolios of the major companies in detail

Geographic Analysis

  • Further breakdown of the RoE animal parasiticides market into Belgium, Russia, the Netherlands, Switzerland, and other countries
  • Further breakdown of the RoLATAM animal parasiticides market into Argentina, Colombia, Chile, and other countries

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Asia Pacific Animal Parasiticides Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Asia Pacific Animal Parasiticides Market

DMCA.com Protection Status